These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 24924839)

  • 1. Interleukin-23 and its correlation with disease activity, joint damage, and functional disability in rheumatoid arthritis.
    Dalila AS; Mohd Said MS; Shaharir SS; Asrul AW; Low SF; Shamsul AS; Sakthiswary R
    Kaohsiung J Med Sci; 2014 Jul; 30(7):337-42. PubMed ID: 24924839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional disability in relation to radiological damage and disease activity in patients with rheumatoid arthritis in remission.
    Molenaar ET; Voskuyl AE; Dijkmans BA
    J Rheumatol; 2002 Feb; 29(2):267-70. PubMed ID: 11842821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased interleukin-23 is associated with increased disease activity in patients with rheumatoid arthritis.
    Guo YY; Wang NZ; Zhao S; Hou LX; Xu YB; Zhang N
    Chin Med J (Engl); 2013 Mar; 126(5):850-4. PubMed ID: 23489789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-9 as an indicator of functional limitations and radiographic joint damage in patients with rheumatoid arthritis.
    Guo J; Ai X; Jia B; Zhong X; Liu L; Hu Q; Xie J; Hong X; Chen Y; Liu D
    Front Immunol; 2024; 15():1419676. PubMed ID: 38957462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High IL-23 level is a marker of disease activity in rheumatoid arthritis.
    Abu Al Fadl EM; Fattouh M; Allam AA
    Egypt J Immunol; 2013; 20(2):85-92. PubMed ID: 24617049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased interleukin 21 (IL-21) and IL-23 are associated with increased disease activity and with radiographic status in patients with early rheumatoid arthritis.
    Rasmussen TK; Andersen T; Hvid M; Hetland ML; Hørslev-Petersen K; Stengaard-Pedersen K; Holm CK; Deleuran B
    J Rheumatol; 2010 Oct; 37(10):2014-20. PubMed ID: 20682664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced concentrations of interleukin 16 are associated with joint destruction in patients with rheumatoid arthritis.
    Lard LR; Roep BO; Toes RE; Huizinga TW
    J Rheumatol; 2004 Jan; 31(1):35-9. PubMed ID: 14705216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 10 (IL-10), not IL-4 or interferon-gamma production, correlates with progression of joint destruction in rheumatoid arthritis.
    Verhoef CM; van Roon JA; Vianen ME; Bijlsma JW; Lafeber FP
    J Rheumatol; 2001 Sep; 28(9):1960-6. PubMed ID: 11550960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do radiographic joint damage and disease activity influence functional disability through different mechanisms? Direct and indirect effects of disease activity in established rheumatoid arthritis.
    Nair SC; Bijlsma JW; van der Werf JH; van der Veen MJ; Linn-Rasker SP; Vreugdenhil S; Lafeber FP; Welsing PM
    J Rheumatol; 2013 Sep; 40(9):1505-12. PubMed ID: 23818710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased serum interleukin 22 in patients with rheumatoid arthritis and correlation with disease activity.
    da Rocha LF; Duarte ÂL; Dantas AT; Mariz HA; Pitta Ida R; Galdino SL; Pitta MG
    J Rheumatol; 2012 Jul; 39(7):1320-5. PubMed ID: 22589261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of serum TWEAK level to cytokine level, disease activity, and response to anti-TNF treatment in patients with rheumatoid arthritis.
    Park MC; Chung SJ; Park YB; Lee SK
    Scand J Rheumatol; 2008; 37(3):173-8. PubMed ID: 18465450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum cytokine and periodontal profiles in relation to disease activity of rheumatoid arthritis in Japanese adults.
    Kobayashi T; Murasawa A; Komatsu Y; Yokoyama T; Ishida K; Abe A; Yamamoto K; Yoshie H
    J Periodontol; 2010 May; 81(5):650-7. PubMed ID: 20429644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-23 in early disease development in rheumatoid arthritis.
    Andersen T; Hvid M; Johansen C; Stengaard-Pedersen K; Hetland ML; Hørslev-Petersen K; Junker P; Østergaard M; Deleuran B
    Scand J Rheumatol; 2015; 44(6):438-42. PubMed ID: 26087654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alveolar bone loss is associated with circulating anti-citrullinated protein antibody (ACPA) in patients with rheumatoid arthritis.
    Gonzalez SM; Payne JB; Yu F; Thiele GM; Erickson AR; Johnson PG; Schmid MJ; Cannon GW; Kerr GS; Reimold AM; Sokolove J; Robinson WH; Mikuls TR
    J Periodontol; 2015 Feb; 86(2):222-31. PubMed ID: 25299390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab treatment reduces the serum levels of interleukin-23 in patients with rheumatoid arthritis.
    Kageyama Y; Kobayashi H; Kato N
    Mod Rheumatol; 2009; 19(6):657-62. PubMed ID: 19685204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between anti-cyclic citrullinated peptide and bone mineral density and radiographic damage in patients with rheumatoid arthritis.
    Guler H; Turhanoglu AD; Ozer B; Ozer C; Balci A
    Scand J Rheumatol; 2008; 37(5):337-42. PubMed ID: 18609264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum levels of Interleukin-37 are associated with inflammatory cytokines and disease activity in rheumatoid arthritis.
    Yang L; Zhang J; Tao J; Lu T
    APMIS; 2015 Dec; 123(12):1025-31. PubMed ID: 26547368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiographic damage in rheumatoid arthritis correlates with functional disability but not direct medical costs.
    Clarke AE; St-Pierre Y; Joseph L; Penrod J; Sibley JT; Haga M; Genant HK
    J Rheumatol; 2001 Nov; 28(11):2416-24. PubMed ID: 11708412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome in rheumatoid arthritis: a simple algorithm of baseline parameters can predict radiographic damage, disability, and disease course at 12-year followup.
    Drossaers-Bakker KW; Zwinderman AH; Vliet Vlieland TP; Van Zeben D; Vos K; Breedveld FC; Hazes JM
    Arthritis Rheum; 2002 Aug; 47(4):383-90. PubMed ID: 12209484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of bone morphogenetic proteins to disease activity and radiographic damage in patients with ankylosing spondylitis.
    Park MC; Park YB; Lee SK
    Scand J Rheumatol; 2008; 37(3):200-4. PubMed ID: 18465455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.